SERA fundamentals
Key facts
Market capitalization146.89 MUSD
Basic EPS (TTM)−0.99USD
Founded2008
CEOEvguenia Lindgardt
Websiteseraprognostics.com
About
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−39,000%
−33,000%
−27,000%
−21,000%
−15,000%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−9.00 M
−6.00 M
−3.00 M
0.00
3.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
SERA does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company